These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9369281)
1. Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat. Velasquez MT; Striffler JS; Abraham AA; Michaelis OE; Scalbert E; Thibault N Hypertension; 1997 Nov; 30(5):1232-7. PubMed ID: 9369281 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension. Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621 [TBL] [Abstract][Full Text] [Related]
3. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518 [TBL] [Abstract][Full Text] [Related]
4. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy. O'Brien RC; Cooper ME; Jerums G; Doyle AE Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112 [TBL] [Abstract][Full Text] [Related]
5. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy in a model combining spontaneous hypertension with diabetes. Cooper ME; Rumble JR; Allen TJ; O'Brien RC; Jerums G; Doyle AE Kidney Int; 1992 Apr; 41(4):898-903. PubMed ID: 1513111 [TBL] [Abstract][Full Text] [Related]
8. Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Velasquez MT; Bhathena SJ; Ranich T; Schwartz AM; Kardon DE; Ali AA; Haudenschild CC; Hansen CT Kidney Int; 2003 Dec; 64(6):2100-7. PubMed ID: 14633132 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. Anderson S; Rennke HG; Brenner BM J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863 [TBL] [Abstract][Full Text] [Related]
10. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats. Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891 [TBL] [Abstract][Full Text] [Related]
11. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity. Duggan KA; Hodge G; Makarious MM; Charlesworth JA Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model. Raij L; Chiou XC; Owens R; Wrigley B Am J Med; 1985 Sep; 79(3C):37-41. PubMed ID: 2996345 [TBL] [Abstract][Full Text] [Related]
13. Effect of carbohydrate intake on kidney function and structure in SHR/N-cp rats. A new model of NIDDM. Velasquez MT; Kimmel PL; Michaelis OE; Carswell N; Abraham A; Bosch JP Diabetes; 1989 Jun; 38(6):679-85. PubMed ID: 2721822 [TBL] [Abstract][Full Text] [Related]
14. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Dworkin LD; Grosser M; Feiner HD; Ullian M; Parker M Kidney Int; 1989 Mar; 35(3):790-8. PubMed ID: 2540376 [TBL] [Abstract][Full Text] [Related]
15. Diabetic renal microvascular disease: the role of hypertension and ACE inhibitors. Cooper ME; Rumble JR; Gin T; Lim-Joon T Clin Exp Pharmacol Physiol Suppl; 1992; 19():23-7. PubMed ID: 1395113 [TBL] [Abstract][Full Text] [Related]
16. Diabetic glomerulopathy in the SHR/N-corpulent rat: role of dietary carbohydrate in a model of NIDDM. Velasquez MT; Abraham AA; Kimmel PL; Farkas-Szallasi T; Michaelis OE Diabetologia; 1995 Jan; 38(1):31-8. PubMed ID: 7744227 [TBL] [Abstract][Full Text] [Related]
17. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881 [TBL] [Abstract][Full Text] [Related]
18. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924 [TBL] [Abstract][Full Text] [Related]
19. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system. Sebeková K; Lill M; Boor P; Heidland A; Amann K Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741 [TBL] [Abstract][Full Text] [Related]
20. Effect of antihypertensive therapy on renal injury in type 2 diabetic rats with hypertension. Reddi AS; Nimmagadda VR; Lefkowitz A; Kuo HR; Bollineni JS Hypertension; 2000 Aug; 36(2):233-8. PubMed ID: 10948083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]